ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HEMO Hemogenyx Pharmaceuticals Plc

1.567
0.002 (0.13%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.002 0.13% 1.567 1.536 1.598 1.55 1.538 1.55 4,833,427 16:35:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.40 17.59M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.59 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.40.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13151 to 13171 of 13425 messages
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older
DateSubjectAuthorDiscuss
27/2/2024
12:02
Now the other thing that as actual shareholders we all know is that at some stage further funding will be required to get through to phases 2 & 3

We just don't know when and how? One possibility is that potentially a major industry player could offer funding as part of a long term collaboration?

But for now all guess work and that is the 100% honest approach!

apotheki
27/2/2024
12:01
Amongst various posts on this HEMO thread including posts 806 & 807 in the very recent past notably September & November 2023 a total of circa £1.25m was raised to add to the existing coffers.

One of those two fund raising was at a substantial premium which could potentially of course be replicated at some point!

So whilst they might raise again soon they might not! And if they do it could once again be at a substantial premium!

None of us know for sure and that includes the TROLL but the above is for balance as well as being based on actual FACTS!

apotheki
27/2/2024
11:54
Prove all of those [what you describe as] FACTS [in other words put up or shut up]

P.S. - we all know that you are just another nickname for that other TROLL starting with d....

apotheki
27/2/2024
11:51
Thanks Log.
premium beeks
27/2/2024
11:50
They are skint FACT! They need to raise FACT! They struggled to raise anything significant last time FACT! There's been no proper institutional interest FACT! There are many many similar firms doing what they do and HEMO seems to be practically unknown in that space FACT!
loglorry1
27/2/2024
11:32
Does it?It may well do, however it could equally be they are undertaking commercially sensitive negotiations and we are in a no news lull. The price isn't dropping in a way that suggests the company is doing the City rounds for funding, it's low volume drip as people move on for more exciting things.You can spin your negative slant how you want, I"ll continue to be objective until firm facts are known.
premium beeks
27/2/2024
11:24
Yes because they are struggling to raise and the share price tells you that.
loglorry1
27/2/2024
11:19
It was below 3p last week and now below 2p.I await the next guess on absolute hot air.
premium beeks
27/2/2024
11:13
They are running on empty and in the last raise only managed enough to keep the lights on for a couple of months. They have FDA green light for Phase 1 but no money to fund it. No serious institutions on the share register and like many other biotech companies out there they seem to be struggling to raise. I think they'll raise money below 2p fwiw and they need to do so quite quickly.
loglorry1
27/2/2024
10:32
Findings
Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells. The journal Blood published the preclinical findings today.

By overcoming challenges, such as drug resistance and treatment relapse common to patients with acute myeloid leukemia (AML), the therapy method could provide a less toxic and more effective approach for older and sicker patients who don't quality for stem cell transplants

Sadly the Hemogenyx CDX platform remains in the Petri Dish, The technology that

raised countless millions in subscriptions from investors to be replaced by the

Cd19flt33 Car-T platform which requires Further First aid from the investors

wallets🍒

dreamtwister
27/2/2024
10:32
Exactly right.It's all guesswork until the company tells us. The silence is deafening at the moment, I'd expect there's a lot of discussions behind closed doors as to what comes next.Meanwhile the price is likely to drift in the interim. Just a fact of life in such a situation.
premium beeks
27/2/2024
10:26
Now the other thing that as actual shareholders we all know is that at some stage further funding will be required to get through to phases 2 & 3

We just don't know when and how? One possibility is that potentially a major industry player could offer funding as part of a long term collaboration?

But for now all guess work and that is the 100% honest approach!

apotheki
27/2/2024
10:23
Amongst various posts on this HEMO thread including posts 806 & 807 in the very recent past notably September & November 2023 a total of circa £1.25m was raised to add to the existing coffers.

One of those two fund raising was at a substantial premium which could potentially of course be replicated at some point!

So whilst they might raise again soon they might not! And if they do it could once again be at a substantial premium!

None of us know for sure and that includes the TROLL but the above is for balance as well as being based on actual FACTS!

apotheki
27/2/2024
10:17
dreamtwister27 Feb '24 - 09:00 - 861 of 862 (Filtered)
dreamtwister27 Feb '24 - 09:17 - 862 of 862 (Filtered)
dreamtwister27 Feb '24 - 09:48 - 864 of 864 (Filtered)

apotheki
27/2/2024
09:40
dreamtwister27 Feb '24 - 09:00 - 861 of 862 (Filtered)
dreamtwister27 Feb '24 - 09:17 - 862 of 862 (Filtered)

apotheki
27/2/2024
09:17
So whilst the Hemogenyx Science remains in Regression ! The science Evolves !

the link above " yes open it & read it " Behind the Scenes the science is

becoming Assessable...Affordable...Oral conception...less time in administration

Risk Adverse "contamination" patient Safety & Age related.

So Dr Sandler Has the Greenlight for the commencement of the clinical trials to

Enroll the patients that has their body clock ticking bye ?

dreamtwister
26/2/2024
19:29
I bet your mum is still in a state of confusion wondering why she didn't swallow.Imagine being so dense that you keep repeating the obvious thinking you have a found a top secret fact. Keep going. If it keeps you busy it's probably good for society overall.
justaman
26/2/2024
11:49
well the above statement by Justaman is in a state of confusion !



The company statement has spelt it out in laymans terms: the cash burn is incinerating our working Capital !

The company Statement.!

“Substantial funding will be required by the Company during the clinical trial phase and further funding will be sought by the Company prior to the commencement of the Phase I clinical trials.🍒

lets wait & see the eoy report !...can post in Brail if you like.

dreamtwister
26/2/2024
10:33
dreamtwister26 Feb '24 - 10:02 - 855 of 855 (Clueless C0ck)
premium beeks
26/2/2024
10:30
dreamtwister26 Feb '24 - 10:02 - 855 of 855 (Filtered)
apotheki
26/2/2024
10:02
justaman... vlad has got to sell the science before going forward !

over the last decade the Major industry pharmaceuticals have taken up

their collaborations ,Though as the new financel year dawns they may take

a vested interest after running the slide rule over the Hemogenyx books no

doubt the v/capitalist mind set will follow ,so will that entail the Pi to take

Dr Sandlers Awarded share Options The Blessing would be for you to study the

WWW.INVESTINGFORDUMMIES.COM manual of common sense ! lets wait & see what the

end of year results reveal. Here is a clue "hence not my Words !

A company Statement.!

“Substantial funding will be required by the Company during the clinical trial phase and further funding will be sought by the Company prior to the commencement of the Phase I clinical trials.

dreamtwister
Chat Pages: 537  536  535  534  533  532  531  530  529  528  527  526  Older

Your Recent History

Delayed Upgrade Clock